Municipal Employees' Retirement System Of Michigan Myriad Genetics Inc Transaction History

Municipal Employees' Retirement System Of Michigan

$7.58 Billion
Q3 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 06, 2020	SELL	$10.69 - $16.49 $246,404 - $380,094	-23,050 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$9.78 - $29.53 $4,303 - $12,993	440 Added 1.95%	23,050 $330,000
Q4 2019 Feb 03, 2020	BUY	$20.93 - $35.1 $10,674 - $17,901	510 Added 2.31%	22,610 $616,000
Q3 2019 Oct 29, 2019	BUY	$22.08 - $47.08 $3,974 - $8,474	180 Added 0.82%	22,100 $633,000
Q2 2019 Jul 31, 2019	BUY	$22.67 - $35.0 $8,614 - $13,300	380 Added 1.76%	21,920 $609,000
Q1 2019 May 15, 2019	SELL	$26.93 - $34.7 $1,885 - $2,429	-70 Reduced 0.32%	21,540 $715,000
Q4 2018 Feb 14, 2019	BUY	$27.23 - $45.56 $51,737 - $86,564	1,900 Added 9.64%	21,610 $628,000
Q2 2018 Jul 19, 2018	SELL	$27.75 - $40.17 $227,272 - $328,992	-8,190 Reduced 29.35%	19,710 $737,000
Q1 2018 May 10, 2018	BUY	$28.83 - $41.01 $57,660 - $82,020	2,000 Added 7.72%	27,900 $824,000
Q4 2017 Feb 15, 2018	BUY	$28.45 - $37.14 $3,983 - $5,199	140 Added 0.54%	25,900 $890,000
Q3 2017 Nov 06, 2017	BUY	$24.01 - $36.2 $618,497 - $932,512	25,760	25,760 $932,000

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.9M

Call Options Held

100K

Put Options Held

34K

Black Rock Inc. New York, NY

15.2M
Shares

$232 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.3M
Shares

$158 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

6.72M
Shares

$103 Million
0.03% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

5.18M
Shares

$79.2 Million
0.07% of portfolio
State Street Corp Boston, MA

4.7M
Shares

$72 Million
0.01% of portfolio

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.23B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Municipal Employees' Retirement System Of Michigan, based on Form 13F filings with the SEC.

News

Stay updated on Municipal Employees' Retirement System Of Michigan with notifications on news.

Account